Comparison of the efficacy and safety of insulin degludec/aspart (twice‐daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal–bolus therapy)

相似書籍

• Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec
  由: Kawaguchi, Yuji, et al.
  出版: (2019)
• Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open‐label, cross‐over study using continuous glucose monitoring profiles
  由: Kawaguchi, Yuji, et al.
  出版: (2018)
• Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
  由: Buscemi, Silvio, et al.
  出版: (2019)
• Response to insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?
  由: Yamabe, Mizuho
  出版: (2019)
• Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study
  由: Takeishi, Soichi, et al.
  出版: (2017)